A Study of Evofosfamide in Combination with Zalifrelimab and Balstilimab
A Study of Evofosfamide in Combination with Zalifrelimab and Balstilimab
Recruiting · NCT06782555 · Registry updated 2025-01-21Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study of Evofosfamide in Combination with Zalifrelimab and Balstilimab | Digestive System Diseases, Digestive System Neoplasms, Genital Diseases, Head and Neck Neoplasms, Male Urogenital Diseases, Neoplasms by Histologic Type, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, carcinoma, endocrine system disorder, epithelial neoplasm, head and neck squamous cell carcinoma, male reproductive organ cancer, male reproductive system disorder, malignant endocrine neoplasm, metastatic prostate carcinoma, neoplasm, pancreas disorder, pancreatic neoplasm, prostate cancer, prostate disorder, squamous cell carcinoma | Recruiting | Phase 1 / Phase 2 | 2025-01-21 | NCT06782555 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Agenus Inc. | 23 |
| ImmunoGenesis | 3 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| MD Anderson Cancer Center | Houston | United States | 589 |